Zymeworks (ZYME) Announces Appointment of Oleg Nodelman, EcoR1 Capital, to Board of Directors
Key Summary: On February 17, 2025, the company announced the appointment of Oleg Nodelman to its board.
Market Cap: $1 billion | Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer.
On February 17, 2025, the company announced the appointment of Oleg Nodelman to its board. Mr. Nodelman is the Founder and Managing Director of EcoR1 Capital, LLC (21.4%) Source
Member discussion